Charlie Rodi
Chief Executive Officer at Rhodx, Inc.
Profile
Charlie Rodi is the founder of Rhodx, Inc. He worked as an Executive Vice President-Genomics at Sequenom, Inc. from 1999 to 2002.
He was also the Chief Technology Officer & Vice President at Cardiff Oncology, Inc. He worked as a Vice President-Research & Development at Sorrento Therapeutics, Inc. from 2009 to 2011.
Dr. Rodi holds a doctorate degree from the University of Minnesota.
Charlie Rodi active positions
Companies | Position | Start |
---|---|---|
Rhodx, Inc.
Rhodx, Inc. Miscellaneous Commercial ServicesCommercial Services Rhodx, Inc. is a technology company based in St. Louis, MO. Rhodx is developing solutions to improve detection and characterization of cancer through their technology overview which includes PointsSuppressor™ - wild type suppression and NexGenAble™ - mutation detection services. The company is focused on the next generation of liquid biopsy. The company was founded by Charlie Rodi and he has been the CEO since incorporation. | Chief Executive Officer | - |
Former positions of Charlie Rodi
Companies | Position | End |
---|---|---|
SORRENTO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2011 |
SEQUENOM, INC. | Corporate Officer/Principal | 01/01/2002 |
CARDIFF ONCOLOGY, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Charlie Rodi
University of Minnesota | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
CARDIFF ONCOLOGY, INC. | Health Technology |
SORRENTO THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
Sequenom, Inc.
Sequenom, Inc. Medical SpecialtiesHealth Technology Sequenom, Inc. engages in the provision of early patient management information. It develops and commercializes molecular diagnostic testing services that serve women's health and oncology markets. The company was founded by Hubert Koester and Charles R. Cantor in October 09, 1996 and is headquartered in Burlington, NC. | Health Technology |
Rhodx, Inc.
Rhodx, Inc. Miscellaneous Commercial ServicesCommercial Services Rhodx, Inc. is a technology company based in St. Louis, MO. Rhodx is developing solutions to improve detection and characterization of cancer through their technology overview which includes PointsSuppressor™ - wild type suppression and NexGenAble™ - mutation detection services. The company is focused on the next generation of liquid biopsy. The company was founded by Charlie Rodi and he has been the CEO since incorporation. | Commercial Services |
- Stock Market
- Insiders
- Charlie Rodi